Debate: Is Bivalirudin Superior to Heparin for ACS Patients? - Gregg Stone, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Coronary - The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Debate: Is Bivalirudin Superior to Heparin for ACS Patients? presented by Gregg Stone, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$3.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: The Thrombin Inhibitors Great Debate: Bivailrudin vs. Heparin

Track: Coronary

Learning Objectives

  • Update in advances in ACS & AMI Management

Other Components in this Moment

Overview
Debate: Is Bivalirudin Superior to Heparin for ACS Patients? - Gregg Stone, MD, FSCAI
Debate: Heparin Should be the First-line Therapy for Patients with ACS/ AMI - A. Michael Lincoff, MD
Loading Simple Education